5. Juli 2020 – To avoid major delays in the labelling phase for human medicinal products, Swissmedic has introduced new measures. For further information, see: https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/authorisations/informationen/optimierung_labelling-phase-ham.html.